Guided Therapeutics (GTHP) EBT Margin (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 103,023.00 |
| Sep 30, 2025 | -54,350.00 |
| Mar 31, 2024 | -549,375.00 |
| Jun 30, 2023 | 41,136.00 |
| Sep 30, 2022 | -1.82 Mn |
| Jun 30, 2022 | -838,000.00 |
| Mar 31, 2022 | -940,000.00 |
| Dec 31, 2021 | -109,789.00 |
| Sep 30, 2021 | 5.21 Mn |
| Dec 31, 2020 | 661,855.00 |
| Dec 31, 2019 | 1.94 Mn |
| Sep 30, 2019 | 25.37 Mn |
| Jun 30, 2019 | -26.51 Mn |
| Mar 31, 2019 | 533,413.00 |
| Dec 31, 2018 | 3.08 Mn |
| Sep 30, 2018 | -8.01 Mn |
| Jun 30, 2018 | 1.57 Mn |
| Mar 31, 2018 | 3.52 Mn |
| Dec 31, 2017 | -99,782.00 |
| Sep 30, 2017 | -593,563.00 |
| Jun 30, 2017 | -72,151.00 |
| Mar 31, 2017 | -92,310.00 |
| Dec 31, 2016 | 63,569.00 |
| Dec 31, 2015 | 785,417.00 |
| Sep 30, 2015 | -1.03 Mn |
| Jun 30, 2015 | -876,000.00 |
| Mar 31, 2015 | -13.57 Mn |
| Dec 31, 2014 | 14.10 Mn |
| Sep 30, 2014 | 605,455.00 |
| Jun 30, 2014 | -2.78 Mn |
| Mar 31, 2014 | 758,146.00 |
| Dec 31, 2013 | -103,250.00 |
| Sep 30, 2013 | 88,380.00 |
| Jun 30, 2013 | -29,854.00 |
| Mar 31, 2013 | 96,953.00 |
| Dec 31, 2012 | -2,499.00 |
| Sep 30, 2012 | 26,982.00 |
| Jun 30, 2012 | -26,863.00 |
| Mar 31, 2012 | -16,706.00 |
| Dec 31, 2011 | 4,752.00 |
| Sep 30, 2011 | 20,630.00 |
| Jun 30, 2011 | -4,033.00 |